Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient

ConclusionsIn critically ill patients, prophylactic dosing of heparin TID versus BID was not associated with differences in new VTE or safety outcomes. Several modifiable VTE risk factors were identified.This article is protected by copyright. All rights reserved.

Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - December 28, 2018 Category: Drugs & Pharmacology Authors: Paul M. Reynolds, Edward T. Van Matre, Garth C. Wright, R. Brett McQueen, Ellen L. Burnham, P. Michael Ho, Marc Moss, R. William Vandivier, Tyree H. Kiser, Colorado Pulmonary Outcomes Research Group (CPOR) Tags: SI on Prevention Strategies in the Critically Ill Source Type: research